BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21931711)

  • 1. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
    Membrino A; Cogoi S; Pedersen EB; Xodo LE
    PLoS One; 2011; 6(9):e24421. PubMed ID: 21931711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.
    Cogoi S; Shchekotikhin AE; Xodo LE
    Nucleic Acids Res; 2014 Jul; 42(13):8379-88. PubMed ID: 25013182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.
    Cogoi S; Zorzet S; Rapozzi V; Géci I; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2013 Apr; 41(7):4049-64. PubMed ID: 23471001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic Acid Targeted Therapy: G4 Oligonucleotides Downregulate HRAS in Bladder Cancer Cells through a Decoy Mechanism.
    Miglietta G; Gouda AS; Cogoi S; Pedersen EB; Xodo LE
    ACS Med Chem Lett; 2015 Dec; 6(12):1179-83. PubMed ID: 26713101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KRAS promoter responds to Myc-associated zinc finger and poly(ADP-ribose) polymerase 1 proteins, which recognize a critical quadruplex-forming GA-element.
    Cogoi S; Paramasivam M; Membrino A; Yokoyama KK; Xodo LE
    J Biol Chem; 2010 Jul; 285(29):22003-16. PubMed ID: 20457603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription.
    Cogoi S; Ferino A; Miglietta G; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2018 Jan; 46(2):661-676. PubMed ID: 29165690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.
    Xodo L; Paramasivam M; Membrino A; Cogoi S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):159-60. PubMed ID: 18776302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells.
    Cogoi S; Paramasivam M; Filichev V; Géci I; Pedersen EB; Xodo LE
    J Med Chem; 2009 Jan; 52(2):564-8. PubMed ID: 19099510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G4 DNA in ras genes and its potential in cancer therapy.
    Cogoi S; Xodo LE
    Biochim Biophys Acta; 2016 Apr; 1859(4):663-74. PubMed ID: 26855080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Poly [ADP-ribose] Polymerase 1 in Activating the
    Cinque G; Ferino A; Pedersen EB; Xodo LE
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp/Krüppel-like transcription factors are essential for the expression of mitochondrial glycerol phosphate dehydrogenase promoter B.
    Hasan NM; MacDonald MJ
    Gene; 2002 Aug; 296(1-2):221-34. PubMed ID: 12383520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G-quadruplex units.
    Podbevšek P; Plavec J
    Nucleic Acids Res; 2016 Jan; 44(2):917-25. PubMed ID: 26656490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1.
    Parks CL; Shenk T
    J Biol Chem; 1996 Feb; 271(8):4417-30. PubMed ID: 8626793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.
    Cogoi S; Paramasivam M; Spolaore B; Xodo LE
    Nucleic Acids Res; 2008 Jun; 36(11):3765-80. PubMed ID: 18490377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake and binding of guanidine-modified phthalocyanines to KRAS/HRAS G-quadruplexes.
    Membrino A; Paramasivam M; Cogoi S; Alzeer J; Luedtke NW; Xodo LE
    Chem Commun (Camb); 2010 Jan; 46(4):625-7. PubMed ID: 20062883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1.
    Parks CL; Shenk T
    J Virol; 1997 Dec; 71(12):9600-7. PubMed ID: 9371624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro.
    Raiber EA; Kranaster R; Lam E; Nikan M; Balasubramanian S
    Nucleic Acids Res; 2012 Feb; 40(4):1499-508. PubMed ID: 22021377
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Marquevielle J; Kumar MVV; Mergny JL; Salgado GF
    Biomol NMR Assign; 2018 Apr; 12(1):123-127. PubMed ID: 29189986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription.
    Cogoi S; Xodo LE
    Nucleic Acids Res; 2006; 34(9):2536-49. PubMed ID: 16687659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A1.
    Miglietta G; Cogoi S; Pedersen EB; Xodo LE
    Sci Rep; 2015 Dec; 5():18097. PubMed ID: 26674223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.